| Validation and development of MTH1 inhibitors for treatment of cancer UW Berglund, K Sanjiv, H Gad, C Kalderen, T Koolmeister, T Pham, ... Annals of oncology 27 (12), 2275-2283, 2016 | 143 | 2016 |
| Chromosome 18 transcriptome profiling and targeted proteome mapping in depleted plasma, liver tissue and HepG2 cells VG Zgoda, AT Kopylov, OV Tikhonova, AA Moisa, NV Pyndyk, ... Journal of Proteome Research 12 (1), 123-134, 2013 | 77 | 2013 |
| Profiling proteoforms: promising follow-up of proteomics for biomarker discovery A Lisitsa, S Moshkovskii, A Chernobrovkin, E Ponomarenko, A Archakov Expert review of proteomics 11 (1), 121-129, 2014 | 74 | 2014 |
| ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery AA Saei, CM Beusch, A Chernobrovkin, P Sabatier, B Zhang, ÜG Tokat, ... Nature communications 10 (1), 5715, 2019 | 72 | 2019 |
| DeMix workflow for efficient identification of cofragmented peptides in high resolution data-dependent tandem mass spectrometry B Zhang, M Pirmoradian, A Chernobrovkin, RA Zubarev Molecular & Cellular Proteomics 13 (11), 3211-3223, 2014 | 72 | 2014 |
| Anticancer effect of deuterium depleted water-redox disbalance leads to oxidative stress X Zhang, M Gaetani, A Chernobrovkin, RA Zubarev Molecular & Cellular Proteomics 18 (12), 2373-2387, 2019 | 68 | 2019 |
| Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs A Chernobrovkin, C Marin-Vicente, N Visa, RA Zubarev Scientific reports 5 (1), 11176, 2015 | 60 | 2015 |
| System-wide identification and prioritization of enzyme substrates by thermal analysis AA Saei, CM Beusch, P Sabatier, JA Wells, H Gharibi, Z Meng, ... Nature communications 12 (1), 1296, 2021 | 56 | 2021 |
| Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project A Archakov, V Zgoda, A Kopylov, S Naryzhny, A Chernobrovkin, ... Expert review of proteomics 9 (6), 667-676, 2012 | 56 | 2012 |
| Cytotoxic and proinflammatory effects of metal-based nanoparticles on THP-1 monocytes characterized by combined proteomics approaches NK Tarasova, A Gallud, AJ Ytterberg, A Chernobrovkin, JR Aranzaes, ... Journal of Proteome Research 16 (2), 689-697, 2017 | 41 | 2017 |
| Exome-driven characterization of the cancer cell lines at the proteome level: the NCI-60 case study MA Karpova, DS Karpov, MV Ivanov, MA Pyatnitskiy, AL Chernobrovkin, ... Journal of proteome research 13 (12), 5551-5560, 2014 | 41 | 2014 |
| DAF-16/FOXO requires Protein Phosphatase 4 to initiate transcription of stress resistance and longevity promoting genes I Sen, X Zhou, A Chernobrovkin, N Puerta-Cavanzo, T Kanno, J Salignon, ... Nature communications 11 (1), 138, 2020 | 38 | 2020 |
| Methionine to isothreonine conversion as a source of false discovery identifications of genetically encoded variants in proteogenomics AL Chernobrovkin, AT Kopylov, VG Zgoda, AA Moysa, MA Pyatnitskiy, ... Journal of proteomics 120, 169-178, 2015 | 32 | 2015 |
| Expression proteomics study to determine metallodrug targets and optimal drug combinations RFS Lee, A Chernobrovkin, D Rutishauser, CS Allardyce, D Hacker, ... Scientific reports 7 (1), 1590, 2017 | 31 | 2017 |
| Is MnSi an itinerant-electron magnet? Results of ESR experiments SV Demishev, AV Semeno, AV Bogach, VV Glushkov, NE Sluchanko, ... JETP Letters 93, 213-218, 2011 | 31 | 2011 |
| Comparative proteomics of dying and surviving cancer cells improves the identification of drug targets and sheds light on cell life/death decisions AA Saei, P Sabatier, ÜG Tokat, A Chernobrovkin, M Pirmoradian, ... Molecular & Cellular Proteomics 17 (6), 1144-1155, 2018 | 29 | 2018 |
| A tale of two tails: efficient profiling of protein degraders by specific functional and target engagement readouts AL Chernobrovkin, C Cázares-Körner, T Friman, IM Caballero, D Amadio, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (4), 534-546, 2021 | 23 | 2021 |
| Proteogenomics of adenosine-to-inosine RNA editing in the fruit fly KG Kuznetsova, AA Kliuchnikova, IU Ilina, AL Chernobrovkin, ... Journal of proteome research 17 (11), 3889-3903, 2018 | 22 | 2018 |
| CETSA MS profiling for a comparative assessment of FDA-approved antivirals repurposed for COVID-19 therapy identifies TRIP13 as a remdesivir off-target T Friman, A Chernobrovkin, D Martinez Molina, L Arnold SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (3), 336-344, 2021 | 21 | 2021 |
| Magnetic properties of vanadium oxide nanotubes and nanolayers SV Demishev, AL Chernobrovkin, VV Glushkov, AV Grigorieva, ... Physical Review B—Condensed Matter and Materials Physics 84 (9), 094426, 2011 | 21 | 2011 |
roman zubarevKarolinska InstitutetVerified email at ki.se
